CME/CE

Episodes 631-645 of 900

• 

  MinuteCE®

  The Frontline of Alzheimer's Care: Addressing Real Questions from Clinicians in the New Dawn of Disease-Modifying Therapy

  • 

    

    Richard S. Isaacson, MD

    Peer

  • 

    

    Pierre N. Tariot, MD

    Peer

  • 

    

    Gayatri Devi, MD, MS, FAAN, FACP

    Peer

  1.25 credits 12 episodes

• 

  RestartResume

  Do Women Respond Differently to ATT Than Men?

  MinuteCE®

  Do Women Respond Differently to ATT Than Men?

  • 

    

    Richard S. Isaacson, MD

    Peer

  • 

    

    Pierre N. Tariot, MD

    Peer

  • 

    

    Gayatri Devi, MD, MS, FAAN, FACP

    Peer

  1.25 program credits

• 

  RestartResume

  Which Amyloid-Targeting Therapy is Best?

  MinuteCE®

  Which Amyloid-Targeting Therapy is Best?

  • 

    

    Richard S. Isaacson, MD

    Peer

  • 

    

    Pierre N. Tariot, MD

    Peer

  • 

    

    Gayatri Devi, MD, MS, FAAN, FACP

    Peer

  1.25 program credits

• 

  MinuteCE®

  Getting SMART about TAVR

  • 

    

    Hemal Gada, MD

    Peer

  • 

    

    Pam R. Taub, MD, FACC, FASPC

    Peer

  • 

    

    Steven Yakubov, MD, MSCAI, FACC

    Peer

  • 

    

    Renuka Jain, MD

    Peer

  • 

    

    Roxana Mehran, MD

    Peer

  • 

    

    Ashish Aneja, MD

    Peer

  • 

    

    Deepak Talreja, MD, FACC

    Peer

  • 

    

    Anene Ukaigwe, MD

    Peer

  • 

    

    Elana Koss, MD

    Peer

  1.00 credits 8 episodes

• 

  RestartResume

  Call to Action: Elevating CKD-aP Care

  CME/CE

  Call to Action: Elevating CKD-aP Care

  • 

    

    Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS

    Peer

• 

  RestartResume

  Contemporary TAVR Outcomes in Patients with Small Aortic Annulus: A Review of Recent Trial Data

  MinuteCE®

  Contemporary TAVR Outcomes in Patients with Small Aortic Annulus: A Review of Recent Trial Data

  • 

    

    Deepak Talreja, MD, FACC

    Peer

  • 

    

    Roxana Mehran, MD

    Peer

  1.00 program credits

• 

  RestartResume

  It’s All About Patient Identification

  MinuteCE®

  It’s All About Patient Identification

  • 

    

    Renuka Jain, MD

    Peer

  1.00 program credits

• 

  RestartResume

  How Should We Monitor Patients on Amyloid-Targeting Therapy?

  MinuteCE®

  How Should We Monitor Patients on Amyloid-Targeting Therapy?

  • 

    

    Richard S. Isaacson, MD

    Peer

  • 

    

    Pierre N. Tariot, MD

    Peer

  • 

    

    Gayatri Devi, MD, MS, FAAN, FACP

    Peer

  1.25 program credits

• 

  RestartResume

  What is the Role of APOE4 Testing in Alzheimer’s Disease?

  MinuteCE®

  What is the Role of APOE4 Testing in Alzheimer’s Disease?

  • 

    

    Richard S. Isaacson, MD

    Peer

  • 

    

    Pierre N. Tariot, MD

    Peer

  • 

    

    Gayatri Devi, MD, MS, FAAN, FACP

    Peer

  1.25 program credits

• 

  RestartResume

  How Do You Counsel Patients About Amyloid-Related Imaging Abnormalities?

  MinuteCE®

  How Do You Counsel Patients About Amyloid-Related Imaging Abnormalities?

  • 

    

    Richard S. Isaacson, MD

    Peer

  • 

    

    Pierre N. Tariot, MD

    Peer

  • 

    

    Gayatri Devi, MD, MS, FAAN, FACP

    Peer

  1.25 program credits

• 

  RestartResume

  Putting Data into Clinical Practice

  MinuteCE®

  Putting Data into Clinical Practice

  • 

    

    Pam R. Taub, MD, FACC, FASPC

    Peer

  • 

    

    Steven Yakubov, MD, MSCAI, FACC

    Peer

  1.00 program credits

• 

  RestartResume

  What Does ARIA Look Like Clinically?

  MinuteCE®

  What Does ARIA Look Like Clinically?

  • 

    

    Richard S. Isaacson, MD

    Peer

  • 

    

    Pierre N. Tariot, MD

    Peer

  • 

    

    Gayatri Devi, MD, MS, FAAN, FACP

    Peer

  1.25 program credits

• 

  RestartResume

  Challenging TAVR Cases

  MinuteCE®

  Challenging TAVR Cases

  • 

    

    Renuka Jain, MD

    Peer

  • 

    

    Steven Yakubov, MD, MSCAI, FACC

    Peer

  1.00 program credits

• 

  RestartResume

  Which Biomarkers Do You Recommend to Confirm Amyloid Positivity?

  MinuteCE®

  Which Biomarkers Do You Recommend to Confirm Amyloid Positivity?

  • 

    

    Richard S. Isaacson, MD

    Peer

  • 

    

    Pierre N. Tariot, MD

    Peer

  • 

    

    Gayatri Devi, MD, MS, FAAN, FACP

    Peer

  1.25 program credits

• 

  RestartResume

  How Much Should We Worry About Amyloid-Related Imaging Abnormalities?

  MinuteCE®

  How Much Should We Worry About Amyloid-Related Imaging Abnormalities?

  • 

    

    Richard S. Isaacson, MD

    Peer

  • 

    

    Pierre N. Tariot, MD

    Peer

  • 

    

    Gayatri Devi, MD, MS, FAAN, FACP

    Peer

  1.25 program credits

• Prev
• 1
• 2
• …
• 41
• 42
• 43
• 44
• 45
• …
• 59
• 60
• Next